Supply of gene therapy medicines via dynamic acquisition system.
The procurement covers the supply of medicinal products for gene therapies through a System of Dynamic Acquisition (SDA). The buyer is a Spanish public health authority, likely serving hospitals or regional health services. Bidders must be authorized pharmaceutical companies with relevant certifications for gene therapy products. The contract value is not specified, but the SDA framework suggests multiple awards over time. The duration is implied to be ongoing under the dynamic system.